Table 4.
The diagnostic value of hepatic fibrosis models for evaluating significant fibrosis, severe fibrosis and cirrhosis.
Fibrosis stage | Variables | Cut-off | AUROC (95% CI) | Se (%) | Sp (%) | PPV (%) | NPV (%) | P-value |
---|---|---|---|---|---|---|---|---|
≥F2 | PSR | 1.531 | 0.777 (0.691–0.849) | 84.15 | 62.86 | 69.38 | 79.86 | <0.05 |
LSR | 8.459 | 0.633 (0.539–0.720) | 86.59 | 37.14 | 57.94 | 73.47 | <0.05 | |
APRI | 0.437 | 0.789 (0.704–0.859) | 73.17 | 74.29 | 74.00 | 73.47 | <0.05 | |
Frons’ index | 7.317 | 0.674 (0.581–0.757) | 64.63 | 68.57 | 67.28 | 65.97 | <0.05 | |
FIB-4 index | 1.121 | 0.704 (0.612–0.785) | 89.02 | 51.43 | 64.70 | 82.41 | <0.05 | |
S-index | 0.099 | 0.696 (0.605–0.778) | 89.02 | 54.29 | 66.07 | 83.18 | <0.05 | |
≥F3 | PSR | 1.29 | 0.808 (0.725–0.875) | 84.21 | 70.00 | 73.73 | 81.59 | <0.05 |
LSR | 6.169 | 0.685 (0.593–0.768) | 71.93 | 60.00 | 64.26 | 68.13 | <0.05 | |
APRI | 0.365 | 0.739 (0.649–0.815) | 89.47 | 53.33 | 65.72 | 83.51 | <0.05 | |
Frons’ index | 7.234 | 0.673 (0.581–0.757) | 75.44 | 56.67 | 63.52 | 69.76 | <0.05 | |
FIB-4 index | 1.121 | 0.684 (0.592–0.767) | 92.98 | 38.33 | 60.12 | 84.52 | <0.05 | |
S-index | 0.099 | 0.672 (0.579–0.756) | 92.98 | 40.00 | 60.78 | 85.07 | <0.05 | |
F4 | PSR | 1.138 | 0.814 (0.731–0.880) | 83.33 | 67.90 | 72.19 | 80.29 | <0.05 |
LSR | 5.377 | 0.671 (0.578–0.755) | 66.67 | 65.43 | 65.85 | 66.25 | <0.05 | |
APRI | 0.402 | 0.711 (0.620–0.791) | 88.89 | 49.38 | 63.72 | 81.63 | <0.05 | |
Frons’ index | 7.675 | 0.722 (0.632–0.801) | 75.00 | 64.20 | 67.69 | 71.97 | <0.05 | |
FIB-4 index | 1.872 | 0.708 (0.617–0.789) | 69.44 | 70.37 | 70.09 | 69.72 | <0.05 | |
S-index | 0.175 | 0.679 (0.587–0.762) | 75.00 | 59.26 | 64.80 | 70.33 | <0.05 |